ICD-10-CM Code For Benign Neuroendocrine Tumors: Group Overview
The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group D3A includes benign neuroendocrine tumors such as carcinoid tumors and other nonmalignant neuroendocrine neoplasms, specified by site when applicable. These ICD-10-CM diagnosis codes are used to document patient encounters for benign neuroendocrine growths, capturing tumor location, symptomatology, and associated clinical complexity. Accurate coding within the ICD-10-CM D3A group supports proper claim adjudication, complete clinical documentation, and appropriate reimbursement.
Customize your policy alerts
Sign up for ICD-10-CM Code For Benign Neuroendocrine Tumors: Group Overview policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
ICD-10-CM D3A: Benign Neuroendocrine Tumors Overview
This group represents benign neuroendocrine tumors arising from neuroendocrine cells in various organs, including the gastrointestinal tract, pancreas, and respiratory system. These diagnoses target endocrine and neuroendocrine tissue neoplasms that are nonmalignant but may affect organ function. Accurate coding is important for clinical documentation and supports appropriate reimbursement by reflecting the benign nature and specific site of the lesion.